Related Experiment Video
Updated: Aug 13, 2026

12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases
Burak Kundakci1,2, Megan R W Barber3, Ann E Clarke3
1Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Arthritis Care & Research
|August 12, 2026
Summary
A revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is being developed. This data-driven process resulted in 39 candidate items across 13 domains for assessing lupus damage.
Area of Science:
- Rheumatology
- Clinical Epidemiology
Background:
- The Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is a crucial tool for assessing long-term damage in systemic lupus erythematosus (SLE).
- A revision is needed to improve its comprehensiveness and relevance.
- This project is supported by SLICC, ACR, and the Lupus Foundation of America.
Purpose of the Study:
- To report the item generation and reduction phase results for a revised SDI.
- To develop a more accurate and comprehensive measure of cumulative organ damage in SLE patients.
Main Methods:
- Item generation involved a comprehensive literature review and a global Delphi exercise with SLE experts and patients.
- Item reduction utilized iterative Delphi rounds and assessment by a dedicated item reduction committee and clinical domain groups.
- Items with low median appropriateness scores (≤4/9) or those not reflecting the damage construct, rarity, or feasibility were excluded.
Main Results:
- The initial generation phase yielded 2,256 items from the Delphi exercise and 117 from literature review, reduced to 226 candidate items.
- The iterative reduction process resulted in 39 candidate items across 13 domains for the revised SDI.
- Eleven original SDI items were removed (e.g., proteinuria, cranial neuropathy), and new items were proposed (e.g., growth failure, adrenal insufficiency).
- Severity-based subitems were proposed for 43.6% (17/39) of the candidate items.
Conclusions:
- A revised SDI has been proposed with 39 candidate items and definitions, developed through a data-driven, expert, and patient consensus process.
- The next steps involve weighting these items and subitems to create a clinical scoring system.
- This revised SDI aims to provide a more refined assessment of long-term damage in SLE.
